Accurate Wealth Management’s Kronos Bio KRON Stock Holding History

Accurate Wealth Management’s Portfolio KRON Stock Details KRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-98	Closed	-$223	–	884
2022 Q4	$223	Buy	+98	New	+$226	﹤0.01%	1582

Other funds holding KRON

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Accurate Wealth Management's KRON Position: Q1 2023 in Review

Accurate Wealth Management sold out of Kronos Bio (KRON) in Q1 2023, closing a stake of 98 shares — an estimated $223 sold.

Accurate Wealth Management first reported a position in KRON in Q4 2022 and held it in 1 quarter. The position peaked at $223 in Q4 2022. 87 funds tracked by Wall St. Rank hold KRON as of Q1 2023.

Accurate Wealth Management reported no remaining Kronos Bio position as of Q1 2023 after selling out during the quarter.
Accurate Wealth Management sold 98 Kronos Bio shares in Q1 2023, an estimated $223.
Accurate Wealth Management first reported a position in Kronos Bio in Q4 2022 and held it in 1 quarter.
Accurate Wealth Management's Kronos Bio position peaked at $223 in Q4 2022.
87 funds tracked by Wall St. Rank held Kronos Bio as of Q1 2023.

Based on Accurate Wealth Management's 13F filing for Q1 2023, filed 13 Apr 2023.